Home/Healthcare/Rare Diseases/Global Neurology & CNS Disorders Market

Global Neurology & CNS Disorders Market - Strategic Insights and Forecasts (2026-2035)

Market Size, Share, Forecasts and Trends Analysis By Therapy Type (Pharmaceuticals, Biologics, Gene Therapies, Cell Therapies, Neurostimulation Devices, Digital Therapeutics), By Drug Class (Antiepileptic Drugs, Dopaminergic Agents, Immunomodulators, CGRP Inhibitors, Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antidepressants and Antipsychotics), By Indication (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine Disorders, Stroke, ALS, Huntington’s Disease, Neuropathic Pain, Autism Spectrum Disorders), By Route of Administration (Oral, Injectable, Intravenous, Intrathecal, Transdermal), By End User (Hospitals, Specialty Neurology Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Homecare Settings), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies), and Geography

$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Global Neurology & CNS Disorders Market Report

Report IDKSI-008728
PublishedJun 2026
Pages151
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Global Neurology & CNS Disorders Market is projected to grow at a CAGR of 6.8% during the forecast period, increasing from USD 172.8 billion in 2026 to USD 311.2 billion by 2035, driven by rising neurological disease prevalence and advancements in precision neurology.

The Global Neurology & CNS Disorders Market is driven by aging populations, increasing neurodegenerative disease burden, expansion of biomarker-based diagnostics, and growing adoption of neurostimulation and precision medicine therapies.

The Global Neurology & CNS Disorders Market is dominated by Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, migraine, and other chronic neurodegenerative and neuroinflammatory disorders.

The Global Neurology & CNS Disorders Market is led by North America due to advanced healthcare infrastructure, strong adoption of biologics, neurotechnology, and rapid integration of AI-driven neurological diagnostics.

The Global Neurology & CNS Disorders Market is restrained by high clinical trial failure rates, limited neurologist availability in low-resource regions, and reimbursement challenges for advanced CNS therapies.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon